Companies / Elite Pharmaceuticals Inc /Nv/

Elite Pharmaceuticals Inc /Nv/

OTC: ELTPCIK 1053369NORTHVALE, NJ

Financials · FY2026

Revenue$148.87M
Net income$44.87M
Total debt$1.39M
Cash$7.11M
Diluted EPS$0.03
Shares outstanding1.08B

Ownership

1.08B shares outstanding · as of Jun 27, 2026
0.00%Institutions
Ownership
Institutions0.00%500
Public float100.00%1,077,195,942

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
Plassche DouglasEVP Operations
——

Institutional holders 1

View all →
HolderValue% of shares
Kelleher Financial Advisors$245<0.01%
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 9, 2026Plassche Douglas
Executive
ExerciseStock Options (right to buy)$75.0K+2.5M
+71.43%
6,000,000
0.56% of shares
low
Jan 9, 2026Plassche Douglas
Executive
ExerciseStock Options (right to buy)—-2.5M
-100.00%
0
0.00% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ELTPCommon StockEquity28659T200BBG000DPZKG9